EARLY-ONSET ALZHEIMER DISEASE
Clinical trials for EARLY-ONSET ALZHEIMER DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY-ONSET ALZHEIMER DISEASE trials appear
Sign up with your email to follow new studies for EARLY-ONSET ALZHEIMER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Alzheimer's proteins in Early-Onset patients
Disease control Recruiting nowThis early-stage trial tests a drug called ALN-APP (mivelsiran) in 60 adults with mild cognitive impairment or mild dementia due to early-onset Alzheimer's disease. The drug is given via a spinal injection to see if it safely lowers certain proteins linked to Alzheimer's in the b…
Matched conditions: EARLY-ONSET ALZHEIMER DISEASE
Phase: PHASE1 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Major study aims to unlock mysteries of Early-Onset Alzheimer's
Knowledge-focused Recruiting nowThis study follows 850 people aged 40-64 with early-onset cognitive impairment to understand how Alzheimer's disease progresses. Participants undergo cognitive tests, brain scans, and genetic analysis, but no experimental treatment is given. The goal is to gather data that could …
Matched conditions: EARLY-ONSET ALZHEIMER DISEASE
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC